CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases... Show more
CVRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where CVRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for CVRX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVRX advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where CVRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVRX as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CVRX turned negative on January 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
The 10-day moving average for CVRX crossed bearishly below the 50-day moving average on December 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CVRX entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.332) is normal, around the industry mean (62.991). P/E Ratio (0.000) is within average values for comparable stocks, (38.209). CVRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.662). CVRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (2.807) is also within normal values, averaging (39.712).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CVRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, CVRX has been closely correlated with STRRP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVRX jumps, then STRRP could also see price increases.
| Ticker / NAME | Correlation To CVRX | 1D Price Change % | ||
|---|---|---|---|---|
| CVRX | 100% | -16.42% | ||
| STRRP - CVRX | 67% Closely correlated | N/A | ||
| GMED - CVRX | 41% Loosely correlated | -1.70% | ||
| AZTA - CVRX | 39% Loosely correlated | +2.56% | ||
| CTKB - CVRX | 36% Loosely correlated | -1.72% | ||
| VREX - CVRX | 36% Loosely correlated | +1.13% | ||
More | ||||
| Ticker / NAME | Correlation To CVRX | 1D Price Change % |
|---|---|---|
| CVRX | 100% | -16.42% |
| Medical/Nursing Services industry (220 stocks) | 5% Poorly correlated | -0.32% |
| Health Services industry (412 stocks) | 1% Poorly correlated | -0.23% |